SGX — REIT Research Notes
Third-party broker context overlaid on SG Stock Lens screening data · 11 REITs covered · Generated 2026-05-30 04:47 UTC
Why this tab exists: The screener's trailing yfinance data lags operational inflections by 3-6 months (e.g. my screener marked Suntec as Weak Screen Match based on FY24 data, but DBS Jan 2026 note shows FY25 DPU grew +13.6%). This page reflects broker context as of the report dates shown. Refresh by re-fetching DBS notes — never rely on the screener alone.
Tier 1
Strongest research alignment — broker-positive context + clear catalyst + screen support
CRPU
Sasseur REIT
Broker Positive
TP S$0.88
+31% upside
20% weight
DBS report: 26 Feb 2026
Current:S$0.670
Yield:9.2%
MAS Lev:25.1%
ICR:5.3x
Review level:-20%
Thesis9.2% yield rising to 9.4% as cost of debt drops 5.3%→3.5%, +13.6% effective DPU growth runway, sponsor-disciplined (walked away from non-accretive Xi'an deal). 4 China outlet malls, 98.8% occupancy, tenant sales +4.3% in 2H.
Caveats100% China exposure (geopolitical + CNY/SGD FX risk). Modest revenue decline (-4% over 3Y) offset by margin expansion.
WatchSponsor injections at fair pricing, Hefei AEI completion, CNY/SGD trend, Chinese retail sales index, tenant sales momentum.
ReviewQuarterly business updates (May, Aug, Nov, Feb)
TS0U
OUE REIT
Broker Positive ↑
TP S$0.45
+14% upside
15% weight
DBS report: 28 Jan 2026
Current:S$0.395
Yield:6.5%
MAS Lev:38.4%
ICR:2.8x
Review level:-15%
ThesisTP raised from $0.40. Salesforce Tower Sydney acquisition in exclusive discussions, Hilton Singapore Orchard hospitality recovery, mid-single-digit Singapore office reversions next 2Y. FY26/27 DPU 2.41/2.57¢.
CaveatsSmaller float = less liquidity. Hilton recovery still nascent. Hospitality cyclicality.
WatchSydney acquisition closing, Hilton RevPAR trajectory, Singapore office reversions, hotel occupancy at Mandarin Orchard.
ReviewQuarterly business updates (Feb, May, Aug, Nov)
DCRU
Digital Core REIT
Broker Positive ↑↑
TP USD0.70
+32% upside
15% weight
DBS report: 5 Feb 2026
Current:USD0.530
Yield:6.3%
MAS Lev:36.5%
ICR:3.9x
Review level:-20%
ThesisTP raised from US$0.53. Frankfurt + Osaka acquisitions, US$15bn sponsor pipeline (right of first refusal), AI-driven data center demand. 32% upside is biggest in list. Pure-play freehold datacentre across USA/Canada/Europe/Japan.
CaveatsTenant concentration (large hyperscalers); tenant default risk; FX volatility on EUR/JPY assets.
WatchHyperscaler tenant credit ratings, new lease/renewal rates, sponsor pipeline injections, Frankfurt asset performance.
ReviewQuarterly business updates (Feb, May, Aug, Nov)
T82U
Suntec REIT
Broker Positive ↑
TP S$1.60
+9% upside
10% weight
DBS report: 20 Mar 2026
Current:S$1.470
Yield:5.3%
MAS Lev:37.3%
ICR:1.7x
Review level:-15%
ThesisFY25 DPU 7.035¢ +13.6% YoY (beat estimates 12%). 65% interest hedge ratio = biggest rate-cut beneficiary in sector. SG retail reversion +15.3%, office +9.6%. P/B 0.72 = 28% NAV discount.
CaveatsGAAP ICR looks scary (1.7x) but excludes JV income from MBFC/ORQ — real coverage is higher. Office/convention exposure structurally challenged long-term.
WatchQuarterly SORA-linked financing cost decline, rental reversion trends, Suntec convention occupancy rebound, management ownership transition.
ReviewSemi-annual results (Jan, Jul)
Tier 2
Screen-aligned notes with specific caveats
HMN
CapitaLand Ascott Trust
Broker Positive
TP S$1.15
+25% upside
15% weight
DBS report: 5 Feb 2026
Current:S$0.920
Yield:6.6%
MAS Lev:38.0%
ICR:4.8x
Review level:-15%
ThesisFY25 RevPAU at 116% of normalised levels. Somerset Liang Court completion 2027 (+192 rooms). FY26/27F DPU 6.1¢/6.1¢ stabilised. S$2.0bn debt headroom for accretive acquisitions.
CaveatsHigh operating costs + interest cost drag. AEI completions pushed back to FY28 (Cavendish, Sydney Central).
WatchHotel RevPAU trends across SG/UK/Japan, AEI delivery dates, capital injections ($30m/$20m FY26/27).
ReviewQuarterly business updates (Feb, May, Aug, Nov)
K71U
Keppel REIT
Broker Positive
TP S$1.05
+11% upside
15% weight
DBS report: 9 Feb 2026
Current:S$0.950
Yield:5.0%
MAS Lev:37.6%
ICR:6.8x
Review level:-15%
ThesisBest-in-class Singapore CBD office (MBFC, ORQ, OFC). Tight Grade A supply 3+ years. 0.8x P/B with 5% forward yield. Retail expansion to ~20% of AUM, recent Australian acquisition at 6.5% NPI yield.
Caveats20%+ overseas exposure (AUD/JPY/KRW FX risk). MBFC Tower 3 stake increase near-term dilutive. FY26 earnings dip from equity fundraising before FY27 recovery.
WatchSingapore office reversions, MBFC Tower 3 contribution, Australian asset NPI yield, equity raise sizing.
ReviewQuarterly business updates (Jan, Apr, Jul, Oct)
J69U
Frasers Centrepoint Trust
Broker Positive
TP S$2.75
+22% upside
10% weight
DBS report: 15 May 2026
Current:S$2.260
Yield:5.4%
MAS Lev:31.8%
ICR:2.7x
Review level:-15%
ThesisDefensive suburban malls (Causeway Point, Northpoint, Tampines 1, Waterway Point). Occupancy cost only 16% (low — room to raise rents). NEX + Waterway Point inorganic runway of S$1.8bn. FY26/27F DPU 12.38¢/12.66¢.
CaveatsJohor RTS launches end-2026 — potential short-term retail leakage. NAV-aligned (no discount). Limited near-term growth.
WatchSponsor injection of NEX/Waterway stakes, Tampines 1 + Hougang Mall reversions, Singapore-Johor RTS impact on suburban traffic.
ReviewQuarterly business updates (Jan, Apr, Jul, Oct)
9A4U
ESR-LOGOS REIT
Broker Positive
TP S$3.20
+33% upside
5% weight
DBS report: 8 May 2026
Current:S$2.400
Yield:6.9%
MAS Lev:47.9%
ICR:2.8x
Review level:-15%
ThesisS$400m FY25 divestments repositioning portfolio. USD$2.0bn sponsor pipeline for accretive acquisitions. Forward yield 6.9-7.0% over next 2Y. 70+ industrial properties across SG/AU/Japan.
CaveatsMAS leverage 47.9% — only 2pp from regulatory cap (highest risk in list). Net income just turned positive after 3 years of losses. Rights issue risk if gearing rises.
WatchGearing each results release (CRITICAL), rights issue announcements, divestment pricing, JPY/AUD FX impact.
ReviewQuarterly business updates (Feb, May, Aug, Nov)
Q5T
Far East Hospitality Trust
Broker Positive
TP S$0.75
+20% upside
5% weight
DBS report: 17 Mar 2026
Current:S$0.625
Yield:4.9%
MAS Lev:29.6%
ICR:2.4x
Review level:-15%
ThesisSingapore tourism + MICE recovery play. 95%+ Singapore by valuation. Fixed income from sponsor master leases ensures stability. Hidden land value worth ~12¢/share. Maiden Nagoya acquisition contributes FY26. P/B 0.66 = 15% NAV discount.
Caveats2% CAGR new room supply (FY25-FY27) could cap rate increases. Hospitality cyclicality.
WatchSingapore RevPAR vs supply growth, MICE event calendar, Village Albert Court / Robertson Quay divestment progress, Nagoya integration.
ReviewSemi-annual results (Jan, Jul)
Tier 3
Research watch only until conditions change
ME8U
Mapletree Industrial Trust
Broker Neutral ↓
TP S$2.05
+5% upside
0% weight
DBS report: 30 Apr 2026
Current:S$1.950
Yield:6.5%
MAS Lev:29.6%
ICR:4.1x
Review level:-10%
ThesisBroker view lowered from positive at $2.45. DPU revised -7-8% from removed acquisitions, US vacancies, swap hedges expiring at higher rates. DBS expects sideways trading.
Caveats73% of interest costs fixed but US data center repositioning unclear. $500-600m US asset sales targeting balance sheet recap.
WatchUS asset sales execution, US data center occupancy recovery, swap hedge expiry impact on FY26 DPU.
ReviewQuarterly business updates (Jul, Oct, Jan, Apr)
8C8U
Centurion Accommodation REIT
Broker Growth Positive
TP S$1.30
+19% upside
0% weight
DBS report: Nov 2025
Current:S$1.090
Yield:1.6%
MAS Lev:18.6%
ICR:5.8x
Review level:-20%
ThesisGROWTH REIT not income. Westlite Mandai MEC expansion to 9,986 beds (mid-2026 to 2030). Forward yield 6.9-7.2% FY26-27F after run-rated. Best-in-class balance sheet (18.6% MAS, 5.8x ICR).
CaveatsTrailing yield only 1.6% — worse than T-bills. P/B 1.25 = 25% premium to NAV. Not for income investors.
WatchWestlite Mandai bed expansion timeline, PBSA student housing UK/AU pipeline, full-year run-rate distribution.
ReviewQuarterly business updates (Feb, May, Aug, Nov)